James Warner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
James Warner has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Christopher John Bulpitt
Department of Medicine, Imperial College London, Hammersmith Campus, London, W12 0NN, UK
2 shared publications - Lisa Burch
Experimental Medicine and Toxicology Imperial College Faculty of Medicine, Hammersmith campus Du Cane Road, London, W12 0NN, UK
2 shared publications Marc Serfaty
Department of Behavioural Sciences and Psychological Medicine, Royal Free and UCL Medical School, London
2 shared publications- Mark Griffin
Department of Primary Care & Population Health, University College London, Royal Free Campus, Rowland Hill St., London, NW3 2PF, UK.
2 shared publications Michael King
2 shared publicationsNicola Pitts
Department of Psychiatry, Imperial College London
2 shared publications
Latest Publications
- 10 March 2016
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 32 (1) , 110-115
Comparison of service utilisation and costs of working age adults and older adults receiving treatment for psychosis and severe non-psychotic conditions in England: implications for commissioning
Objective Current plans in the English National Health Service are to replace block contracts for mental health providers with a single tariff for each ‘cluster’ of conditions. A single tariff will not take into account the potential additional complexity and costs inherent in caring for older people. To examine the basis for a uniform tariff, differences in service utilisation and costs between working age adults and older adults in two populous clusters (non-psychotic, psychotic) were investigated across five mental health healthcare providers in and around London. Methods Retrospective review of records over 3 months assessing service utilisation and costs using the Client Services Receipt Inventory. Results Records of 362 patients were reviewed, 179 older adults (90 non-psychotic, 89 psychotic) and 183 adults of working age (83 non-psychotic, 100 psychotic). Older adults in both clusters had more tests, assessments and home visits. Overall costs of care of older adults were significantly higher in the non-psychotic cluster (£5634, vs £4405 psychotic, p = 0.044). Conclusions An appropriate age-related tariff is required for each cluster. Copyright © 2016 John Wiley & Sons, Ltd.
- 10 March 2016
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 32 (1) , 110-115
Comparison of service utilisation and costs of working age adults and older adults receiving treatment for psychosis and severe non-psychotic conditions in England: implications for commissioning
Objective Current plans in the English National Health Service are to replace block contracts for mental health providers with a single tariff for each ‘cluster’ of conditions. A single tariff will not take into account the potential additional complexity and costs inherent in caring for older people. To examine the basis for a uniform tariff, differences in service utilisation and costs between working age adults and older adults in two populous clusters (non-psychotic, psychotic) were investigated across five mental health healthcare providers in and around London. Methods Retrospective review of records over 3 months assessing service utilisation and costs using the Client Services Receipt Inventory. Results Records of 362 patients were reviewed, 179 older adults (90 non-psychotic, 89 psychotic) and 183 adults of working age (83 non-psychotic, 100 psychotic). Older adults in both clusters had more tests, assessments and home visits. Overall costs of care of older adults were significantly higher in the non-psychotic cluster (£5634, vs £4405 psychotic, p = 0.044). Conclusions An appropriate age-related tariff is required for each cluster. Copyright © 2016 John Wiley & Sons, Ltd.
- 1 November 2015
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 207 (5) , 375-376
Old age psychiatry in the modern age
Summary: Old age psychiatry services globally are under threat. The discipline enjoyed its heyday in the two decades bridging the millennium. More recently there has been a move to integrate old age services with those of working age adults, to create ‘ageless' services. Evidence is beginning to accumulate that this is a bad idea.
- 1 November 2015
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 207 (5) , 375-376
Old age psychiatry in the modern age
Summary: Old age psychiatry services globally are under threat. The discipline enjoyed its heyday in the two decades bridging the millennium. More recently there has been a move to integrate old age services with those of working age adults, to create ‘ageless' services. Evidence is beginning to accumulate that this is a bad idea.
- Open Access
- 8 April 2014
- Published by Elsevier in International Psychogeriatrics
- Vol. 26 (7) , 1055-1058
Wither old age psychiatry?
- 8 April 2014
- Published by Elsevier in International Psychogeriatrics
- Vol. 26 (7) , 1055-1058
Open AccessWither old age psychiatry?
- 5 August 2013
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 28 (9) , 987
Redefining old age psychiatry—a pragmatic approach
- 5 August 2013
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 28 (9) , 987
Redefining old age psychiatry—a pragmatic approach
- 1 June 2013
- Published by Elsevier in The Lancet
- Vol. 381 (9882) , 1985
Psychiatry for the elderly in the UK
- 1 June 2013
- Published by Elsevier in The Lancet
- Vol. 381 (9882) , 1985
Psychiatry for the elderly in the UK
- Open Access
- 1 March 2013
- Published by Cambridge University Press (CUP) in The Psychiatrist
- Vol. 37 (3) , 116-117
Response
- 1 March 2013
- Published by Cambridge University Press (CUP) in The Psychiatrist
- Vol. 37 (3) , 116-117
Open AccessResponse
- Open Access
- 6 December 2012
- Published by Springer Nature
Randomised controlled Evaluation of Home treatment for Older People with Mental Illness
- 6 December 2012
- Published by Springer Nature
Open AccessRandomised controlled Evaluation of Home treatment for Older People with Mental Illness
- Open Access
- 13 May 2010
- Published by Springer Nature in Trials
- Vol. 11 (1) , 53
Evaluation of exercise on individuals with dementia and their carers: a randomised controlled trial
Background: Almost all of the 820,000 people in the UK with dementia will experience Behavioural and Psychological Symptoms of Dementia (BPSD). However, research has traditionally focused on treating cognitive symptoms, thus neglecting core clinical symptoms that often have a more profound impact on living with dementia. Recent evidence (Kales et al, 2007; Ballard et al, 2009) indicates that the popular approach to managing BPSD - prescription of anti-psychotic medication - can increase mortality and the risk of stroke in people with dementia as well as impair quality of life and accelerate cognitive decline. Consequently, there is a need to evaluate the impact that non-pharmacological interventions have on BPSD; we believe physical exercise is a particularly promising approach. Methods/Design: We will carry out a pragmatic, randomised, single-blind controlled trial to evaluate the effectiveness of exercise (planned walking) on the behavioural and psychological symptoms of individuals with dementia. We aim to recruit 146 people with dementia and their carers to be randomized into two groups; one will be trained in a structured, tailored walking programme, while the other will continue with treatment as usual. The primary outcome (BPSD) will be assessed with the Neuropsychiatric Inventory (NPI) along with relevant secondary outcomes at baseline, 6 and 12 weeks. Discussion: Designing this study has been challenging both ethically and methodologically. In particular to design an intervention that is simple, measurable, safe, non-invasive and enjoyable has been testing and has required a lot of thought. Throughout the design, we have attempted to balance methodological rigour with study feasibility. We will discuss the challenges that were faced and overcome in this paper. Trial Registration: ISRCTN01423159
- 13 May 2010
- Published by Springer Nature in Trials
- Vol. 11 (1) , 53
Open AccessEvaluation of exercise on individuals with dementia and their carers: a randomised controlled trial
Background: Almost all of the 820,000 people in the UK with dementia will experience Behavioural and Psychological Symptoms of Dementia (BPSD). However, research has traditionally focused on treating cognitive symptoms, thus neglecting core clinical symptoms that often have a more profound impact on living with dementia. Recent evidence (Kales et al, 2007; Ballard et al, 2009) indicates that the popular approach to managing BPSD - prescription of anti-psychotic medication - can increase mortality and the risk of stroke in people with dementia as well as impair quality of life and accelerate cognitive decline. Consequently, there is a need to evaluate the impact that non-pharmacological interventions have on BPSD; we believe physical exercise is a particularly promising approach. Methods/Design: We will carry out a pragmatic, randomised, single-blind controlled trial to evaluate the effectiveness of exercise (planned walking) on the behavioural and psychological symptoms of individuals with dementia. We aim to recruit 146 people with dementia and their carers to be randomized into two groups; one will be trained in a structured, tailored walking programme, while the other will continue with treatment as usual. The primary outcome (BPSD) will be assessed with the Neuropsychiatric Inventory (NPI) along with relevant secondary outcomes at baseline, 6 and 12 weeks. Discussion: Designing this study has been challenging both ethically and methodologically. In particular to design an intervention that is simple, measurable, safe, non-invasive and enjoyable has been testing and has required a lot of thought. Throughout the design, we have attempted to balance methodological rigour with study feasibility. We will discuss the challenges that were faced and overcome in this paper. Trial Registration: ISRCTN01423159
- 1 January 2010
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 18 (1) , 21-32
Empowerment in Older Psychiatric Inpatients: Development of the Empowerment Questionnaire for Inpatients (EQuIP)
- 1 January 2010
- Published by Elsevier in The American Journal of Geriatric Psychiatry
- Vol. 18 (1) , 21-32
Empowerment in Older Psychiatric Inpatients: Development of the Empowerment Questionnaire for Inpatients (EQuIP)
- 19 January 2009
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 24 (2) , 213
Ginkgo Biloba trial: response by McCarney et al.
- 19 January 2009
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 24 (2) , 213
Ginkgo Biloba trial: response by McCarney et al.